Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.
Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.
The purpose of the study is to assess the relevance of the advices provided by the IPRA©
 smartphone application for guiding the responses of insulin pump treated type 1 diabetes
 patients using real-time continuous glucose monitoring.
Patients will be asked to evaluate the IPRA advices by connecting to IPRA© application by
 using their smartphone, 30 times a week for two weeks. At the end of this two week period, a
 satisfaction questionnaire will be completed.
Inclusion Criteria:

 -  men and women ≥ 18 years of age,

 -  patients with type 1 diabetes for more than 2 years,

 -  patients treated by insulin pump for more than 6 months,

 -  patients using of real-time continuous glucose monitoring for more than 3 months,

 -  patients able to evaluate the IPRA advices by connecting to IPRA© application 30 times
 a week,

 -  patient able to provide written informed consent,

 -  patient able to provide written non-disclosure agreement

 Exclusion Criteria:

 -  pregnancy or breastfeeding,

 -  current infectious disease,

 -  patients with no smartphone® or Internet access,

 -  adults legally protected (under judicial protection, guardianship, or supervision),
 persons deprived of their liberty